Abiomed (Nasdaq:ABMD) today announced the first patient in the world was successfully treated with its Impella Bridge-to-Recovery (BTR) as part of an early feasibility study.
The first implant was performed by Dr. Duc Thinh Pham and Dr. Jane Wilcox at Northwestern Medicine Bluhm Cardiovascular Institute in Chicago.
Impella BTR is a forward flow heart pump that is implanted through the axillary artery and is placed in the left ventricle. Danvers, Massachusetts-based Abiomed designed the implant to pump more than six liters of blood per minute.
